6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... inhibitors in CVD ... and CKD. ... patients with CKD ... #CVD #CKD
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
history of premature CHD ... history of premature CHD ... individuals exhibit CHD ... Family history of CHD ... Family history, CHD
Generalized Weakness - Differential Diagnosis Framework
"l feel weak":
 • Infectious: Influenza, EBV, PNA, Bacteremia, Sepsis
 •
- Differential Diagnosis ... Infectious: Influenza, EBV ... Sepsis • Kidneys: CKD ... /Heme: CHF, valves ... Rhabdomyolysis, Critical
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... factors: Age>60, CKD ... , CHF, high rate ... Reactions #hematology #diagnosis ... #comparison #table
Dilated Common Bile Duct on POCUS
50's yo patient with RUQ abd pain. Vitals stable/afebrile. Labs: WBC
Vitals stable/afebrile ... mass in distal CBD ... Diagnosed with cholangiocarcinoma ... RJonesSonoEM #Dilated #CBD ... #clinical #biliary
Fungal Biomarkers: Beta-D-Glucan and Aspergillus Galactomannan
Beta-D-Glucan:
 • Polysaccharide cell wall component of many fungi
 • Pathogens:
cut-offs defined in clinical ... SOT recipients, CGD ... Clav (may be + as long ... Galactomannan #diagnosis ... #comparison